Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins

Jingyi Tang1, Zhiyu Cao2, Ming Lei1

  • 1Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou City, Guangdong Province, MN 510120, China.

Abstract

Insights

Brain atrophy rates vary in mild cognitive impairment (MCI) and link to plasma proteins. These proteins influence long-term cognition, showing protective or adverse effects based on atrophy speed.

Area of Science:

  • Neuroscience
  • Biomarkers
  • Neurology

Background:

  • Cerebral atrophy rate heterogeneity is common in mild cognitive impairment (MCI).
  • This heterogeneity may involve microglia-related neuropathology.
  • It can impact cognitive outcomes in MCI patients.

Purpose of the Study:

  • Explore cerebral atrophy rate heterogeneity in MCI.
  • Investigate associations with plasma proteins linked to microglia activity.
  • Examine interaction effects on long-term cognitive changes.

Main Methods:

  • Utilized Group-Based Multi-Trajectory Modeling (GBMT) to identify atrophy rate classes.
  • Employed generalized linear models to assess associations with plasma proteins.
  • Applied Linear Mixed Effect Models (LME) for interaction effects on cognition.

Main Results:

  • Identified two classes: slow-atrophy and fast-atrophy.
  • Found associations between atrophy heterogeneity and plasma proteins (AXL, CD40, TNF-R2).
  • Observed interaction effects: CD40 linked to faster decline in slow-atrophy; AXL/TNF-R2 to slower decline in fast-atrophy.

Conclusions:

  • MCI brain atrophy rate heterogeneity correlates with plasma microglia-related proteins.
  • These proteins exert differential effects on long-term cognition.
  • Effects depend on the individual's rate of cerebral atrophy.